Oric Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2025.
  • Oric Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2025 was $302K, a 15.7% increase year-over-year.
  • Oric Pharmaceuticals, Inc. annual Depreciation for 2024 was $1.11M, a 7.27% increase from 2023.
  • Oric Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.03M, a 6.83% increase from 2022.
  • Oric Pharmaceuticals, Inc. annual Depreciation for 2022 was $966K, a 7.69% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $302K +$41K +15.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 $261K +$8K +3.16% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 $253K +$2K +0.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q1 2022 $251K +$22K +9.61% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $229K -$21K -8.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $250K +$8K +3.31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $242K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.